FindTrial
Sign In

Study comparing the performance status assessments reported by clinician versus patients themselves.

Is patients self-reported performance status comparable to the clinician-reported performance status in predicting 30-day morbidity - a prospective comparative study from a tertiary cancer center in south India. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/064160
Enrollment
125
Registered
2024-03-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: NIL: NIL

Sponsors

Dr Nandini Devi R
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients who are planned for first cycle of cytotoxic chemotherapy

Exclusion criteria

Exclusion criteria: Those who cannot read,comprehend and answer the study questionnaire

Design outcomes

Primary

MeasureTime frame
level of agreement between patient-assessed and clinician-assessed performance status and compare the odds of these assessments in predicting 30-day morbidityTimepoint: Day 1 and Day-30—

Secondary

MeasureTime frame
Correlation of Performance status assessments with 30-day morbidityTimepoint: 30-day morbidity—

Countries

India

Contacts

Public ContactDr Nandini Devi R

Malabar Cancer Centre

drnandiniamutha@gmail.com04902399255

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026